Prevalence of HIV and associated sociobehavioral factors among men with urethral discharge syndrome attending public health facilities in Kampala, Uganda Authors: Annet Aketoko Onzia, Vivian Nakate, Brenda M. Dawa, Barbara Castelnuovo, Steven J. Reynolds, Rosalind Parkes-Ratanshi, Tza-Huei Wang, Yukari C. Manabe, Johan H. Melendez, Matthew M. Hamill Published: 2026 ABSTRACT IntroductionEpidemiological data on HIV infection in male urethral discharge syndrome (UDS) in Africa are limited. We describe the prevalence of HIV and associated demographic and sociobehavioral factors among men with UDS in selected public clinics in Kampala, Uganda.MethodsWithin a cross-sectional study of men seeking care for UDS from October 2019 to July 2022, we performed interviewer-administered demographic and sociobehavioral questionnaires. Point-of-care (POC) rapid sequential algorithmic HIV testing was conducted. Bivariate and adjusted multivariable log-binomial regression analyses were performed to determine factors associated with HIV.ResultsOf 450 male participants, 441(98%) were included in this analysis; 9 declined HIV testing. Median (IQR) age was 24 (22–32) years, 87% (n = 384) reported a previous HIV test. Overall, 18.4% (n = 81) were people living with HIV (PLWHIV). Of these, 86.4% and 13.6% were aged ≥ 25 and < 25 years, respectively. Overall, 8.6% (n = 7) were newly diagnosed with HIV; of those, 42.9% (n = 3) were aged < 25 years. While 94% (70/74) with known HIV reported antiretroviral therapy (ART) use, 52.9% (n = 37) had suppressed viral loads by self-report. Five of the 441 participants (1.1%) reported ‘always’ condom use, 45.4% (n = 200) reported transactional sex, 59.6% (n = 263) ≥ 2 sexual partners in the past six months; 46.7% (n = 206) had notified their partners of UDS symptoms. Multivariable analysis demonstrated significant associations between HIV and older age ≥ 25 years (aPR,6.35; 95% C.I., 3.44–11.75; P < 0.001), and hazardous alcohol use (aPR,1.62; 95% C.I., 1.03–2.54; P = 0.038).ConclusionsAlmost one in five men presenting with UDS were PLWHIV, with just over half of those on ART reporting viral suppression. Older age and hazardous alcohol use were associated with HIV. Men with UDS represent a key population where HIV diagnosis, prevention, and ART adherence interventions may have a significant impact.Supplementary InformationThe online version contains supplementary material available at https://doi.org/10.1186/s12879-026-13758-w. Introduction Sexually transmitted infections (STIs) pose a significant global public health challenge [1]. Between 1990 and 2019, Sub-Saharan Africa (SSA) recorded the highest age-standardized incidence of STIs globally, nearly 20,000 per 100,000 person-years, especially among adolescents and males [2]. SSA also bears the highest incidence of HIV [3]. STIs serve as biomarkers for sexual behaviors that increase the likelihood of acquiring and transmitting HIV [4, 5]. Timely diagnosis and treatment of STIs can reduce the biological susceptibility to HIV infection and onward transmission associated with untreated infections, such as decreased mucosal integrity and increased viral shedding [6]. The World Health Organization (WHO) recommends the integration of HIV and STI services, ideally delivered on the same day and at the same location, to ensure comprehensive and accessible care, including enhanced STI prevention, screening, and treatment for all people living with HIV (PLHIV), and intensified HIV prevention services for individuals diagnosed with STIs [7]. Despite efforts to expand access to care, engaging heterosexual men in HIV prevention and treatment programs in SSA is challenging [8]. Cultural norms and traditional gender roles discourage men from seeking health services, contributing to delayed diagnoses, high attrition from HIV diagnosis to antiretroviral therapy (ART) initiation [8], unsuppressed HIV viral loads, and increased transmission risk [9, 10]. While the region has made strides in reducing new infections and AIDS-related deaths, SSA continues to have the highest global HIV prevalence, with disproportionately high mortality among men and boys [11]. The HIV prevalence among Ugandan men aged 15–49 was 3.6% in 2023, with 11,000 new infections reported; 3,000 (27.3%) of these were among adolescent and young men aged 15–24. Men aged ≥ 15 years accounted for approximately 39% of all AIDS-related deaths in the same year [12]. These statistics highlight the need to prioritize HIV prevention, diagnosis, and treatment efforts among men. This analysis had two aims: (1) to assess the prevalence of new and previously diagnosed HIV infections and (2) to examine sociobehavioral factors associated with HIV among men with urethral discharge syndrome (UDS) in Kampala, Uganda. Methods Study design A cross-sectional study among men with UDS who attended six public health facilities for medical care in Kampala district between October 2019 and July 2022. Study setting This study was conducted in Kampala, Uganda’s capital. Data were collected from sites participating in the WHO’s Enhanced Gonococcal Antimicrobial Surveillance Programme (EGASP) [13] implemented in selected high-volume public health facilities providing general (non-specialised STI) care. The participating facilities were purposively selected by EGASP based on high patient volumes, capacity to diagnose and manage STIs in accordance with national guidelines, availability of trained clinical staff, and suitable specimen handling infrastructure. Sites included the Infectious Diseases Institute HIV clinic and health facilities managed by the Kampala Capital City Authority: Kisenyi Health Centre IV, Kawaala Health Centre III, and the Kiswa/Naguru teenage center. EGASP enrolls consecutive men presenting with self-reported UDS. Penile-meatal swabs are collected on-site and transported daily to a central reference laboratory for culture, identification, and antimicrobial susceptibility testing. For this analysis, potential participants first completed their routine, standard of care (SOC) visit, during which EGASP samples were collected, and where they were treated syndromically by the host clinic for UDS according to national guidelines. After completion of their SOC visit, they were subsequently referred to the study team for screening and enrolment. Study procedures The study methods of the two studies from which data were drawn have been reported elsewhere [14, 15]. In brief, potential participants with self-reported UDS as their primary complaint were introduced to the research study staff by the treating clinician after completion of their SOC clinic visit. The SOC visit should have included rapid HIV testing and UDS treatment per contemporary Ugandan national guidelines [16]. Viral load (VL) suppression (by self-report) was considered as < 1000 copies/mL [16]. Eligible participants were men aged ≥ 18 years who were either seen at SOC visits for initial STI management or returning for suspected STI treatment failure (persistence of symptoms after completing an initial course of therapy), at least 21 days after their initial visit, had at least one sexual partner in the past six months, and were able to comply with study procedures. We also included emancipated minors; individuals aged < 18 years who are married, have a child, or are self-sufficient according to Ugandan guidelines for research [17]. Urethral Discharge syndrome was defined as the presence of any of the following: visible urethral discharge, burning or pain on urination, urethral itching or irritation, discomfort along the urethra, and increased urinary frequency or urgency. Data collection Laboratory samples were collected, and demographic, behavioral, and clinical data were gathered through questionnaires administered by trained research nurses in either Luganda (the predominant local language) or English. The questionnaire was administered in a quiet, private setting to ensure confidentiality, promote participant comfort, and encourage honest and open communication about sexual behaviour (Supplemental file 1). The questionnaires, developed by the study team and refined to reflect the sociocultural context of the intended study population, have been previously published [18]. Subject matter experts and local leaders assessed the questionnaire for validity, reliability, and cultural appropriateness, resulting in necessary modifications. We undertook a pilot study with five respondents at one study site to ensure that questions were clear and easily understood. Questions considered ambiguous, unclear, or likely to cause biased responses were removed. The questionnaire included neutral open-ended questions to reduce social desirability bias. Alcohol consumption patterns were captured using the Alcohol Use Disorders Identification Test (AUDIT-C) tool [19], which has been used in Ugandan HIV care settings and population-based surveys to assess hazardous alcohol use [20, 21]. Data were captured electronically using Research Electronic Data Capture (REDCap) (Vanderbilt University, Nashville, TN, USA) software and backed up daily on a secure, access-restricted central server. Range and consistency checks were performed automatically during data entry. All questions required responses, though participants could choose ‘do not know’ or ‘prefer not to say’. Data quality control, including checks for completeness, was conducted weekly or biweekly by the study data manager. Study laboratory procedures HIV testing was performed at the clinical site by the study team using a whole blood point-of-care (POC) rapid test, Determine (Standard Diagnostics, Giheung-gu, Republic of Korea), confirmed with STAT-PAK (Chembio, Medford, NY, US) if positive. Discrepant results were adjudicated with Uni-Gold™ (Trinity Biotech, Ireland) as a tiebreaker, per Ugandan Ministry of Health recommendations [16]. Participants were informed of their rapid test results, and those with a new HIV diagnosis were referred for additional testing and linked to care for ART initiation. Statistical analysis Descriptive statistical analyses were performed, stratified by HIV serostatus. Chi-square tests or Fisher’s exact tests were used as appropriate to compare categorical variables, such as self-reported HIV status before study entry. Factors with a p-value of < = 0.2 at bivariate analysis were included in the multivariate analysis, with the model fitted on 437 complete cases. Log-binomial regression was used to identify factors associated with HIV among men with UDS. Prevalence ratios and 95% confidence intervals (CIs) assessed the relationship between HIV and variables such as age and condomless sex. All statistical analyses were conducted using STATA 17 (College Station, Texas, USA). Ethical considerations Ethical oversight was provided by the Joint Clinical Research Centre at Makerere University (JC0919 and JC1920) and the Ugandan National Council for Science and Technology (HS455ES and HS1338ES) and approved by the Institutional Review Board at Johns Hopkins University (Baltimore, MD, USA) (IRB00273945 and IRB00215298). No study procedures were carried out until signed informed consent was obtained in Luganda (local language) or English, depending on participant preference. All patients received antimicrobial treatment for UDS by their clinical team according to Ugandan clinical guidelines [16], before study enrolment. Participants received 20,000 UGX (~ $5.7 USD) as travel compensation, and all study procedures were provided free of charge to enrolled participants. Results Of 450 men with UDS enrolled, 98% (N = 441) were included in this analysis; nine participants declined HIV testing, with three (of 9) reporting that they were already living with HIV, and six were of unknown HIV status. Table 1 describes clinical, sociodemographic, and behavioral characteristics of participants by HIV status. The median age was 24 years (IQR 22–32). Less than half had notified their partners of STI symptoms before the clinic visit. The majority (87%; 384 of 441) reported a previous HIV test. Overall, 18.4% (n = 81) had a positive HIV result; 91.4% (74/81) were known PLHIV before joining the study. Most, 94.6% (70/74), reported taking ART, though only 52.9% (37/70) reported viral suppression. Table 1Sociodemographic and behavior data characteristics stratified by HIV status for participants with UDS attending public health facilities in Kampala, UgandaVariableTotal,N = 441N (%)HIV statusPositiven = 81 (18.4%)n (%)Negativen = 360 (81.6%)n (%) Age Categories < 25233 (52.8)11 (13.6)222 (61.7) ≥ 25208 (47.2)70 (86.4)138 (38.3) Self-reported HIV status (before study entry) Positive74 (16.8)74 (91.4)0 (0.0) Negative310 (70.3)4 (4.9)306 (85.0) Unknown57 (12.9)3 (3.7)54 (15.0) Taking ART Yes70 (15.9)70 (86.4)0 (0.0) No371 (84.1)11 (13.6)360 (100.0)Self-reported Viral Load status (before study entry), (n = 70) Suppressed37 (52.9)37 (52.9)0 (0.0) Unsuppressed24 (34.3)24 (34.3)0 (0.0) Unknown9 (12.8)9 (12.8)0 (0.0) Number of sexual partners in the past 6 Months None6 (1.4)1 (1.2)5 (1.4) 1172 (39.0)35 (43.2)137 (38.1) ≥ 2263 (59.6)45 (55.6)218 (60.5)Median (IQR)2 (1–3)2 (1–2)2 (1–3) Condom use in the last 6 Months Always5 (1.1)1 (1.2)4 (1.1) Sometimes219 (49.7)40 (49.4)179 (49.7) Never217 (49.2)40 (49.4)177 (49.2) Number of UDS episodes in the past 6 Months None6 (1.4)1 (1.2)5 (1.4) 1291 (66.0)47 (58.0)244 (67.8) ≥ 2144 (32.6)33 (40.7)111 (30.8) Median (IQR)1 (1–2)1 (1–2)1 (1–2) Transactional sex in the past 6 months Yes200 (45.4)36 (44.4)164 (45.6) No241 (54.6)45 (55.6)196 (54.4) Alcohol intake in the last 6 Months Yes202 (45.8)51 (63.0)151 (41.9) No239 (54.2)30 (37.0)209 (58.1) Alcohol assessment (Audit-C scores) 0 (or no alcohol use)240 (54.4)30 (37.0)210 (58.3) 1–3115 (26.1)26 (32.1)89 (24.7) ≥ 486 (19.5)25 (30.9)61 (16.9)Illicit drug use in the past 6 Months (n = 439) d Yes39 (8.9)5 (6.2)34 (9.5) No400 (91.1)76 (93.8)324 (90.5) Partner notified of STI symptoms prior to clinic visit Yes206 (46.7)40 (49.4)166 (46.1) No235 (53.3)41 (50.6)194 (53.9)Sexual activity with UDS symptoms (n = 439)d Yes, with a condom20 (4.5)6 (7.6)14 (3.9) Yes, without a condom78 (17.8)22 (27.8)56 (15.6) No341 (77.7)51 (64.6)290 (80.5) Duration of UDS symptoms (days) 18 (1.8)1 (1.2)7 (1.9) 2–5183 (41.5)21 (25.9)162 (45.0) 6–996 (21.8)16 (19.8)80 (22.2) 10–1464 (14.5)17 (21.0)47 (13.1) > 1490 (20.4)26 (32.1)64 (17.8)UDS, Urethral Discharge Syndrome, M, month(s)d missing values; Sexually active since developed symptoms (n = 2, 0.5%), Drug use in past 6 months (n = 439, 0.5%). Participants who declined to answer the 2 questions were considered as missingThe Audit-C Score tool was used to identify participants who are hazardous drinkers or have active alcohol use disorders, with a score of 4 or higher indicative of hazardous alcohol intake Table 1Sociodemographic and behavior data characteristics stratified by HIV status for participants with UDS attending public health facilities in Kampala, UgandaVariableTotal,N = 441N (%)HIV statusPositiven = 81 (18.4%)n (%)Negativen = 360 (81.6%)n (%) Age Categories < 25233 (52.8)11 (13.6)222 (61.7) ≥ 25208 (47.2)70 (86.4)138 (38.3) Self-reported HIV status (before study entry) Positive74 (16.8)74 (91.4)0 (0.0) Negative310 (70.3)4 (4.9)306 (85.0) Unknown57 (12.9)3 (3.7)54 (15.0) Taking ART Yes70 (15.9)70 (86.4)0 (0.0) No371 (84.1)11 (13.6)360 (100.0)Self-reported Viral Load status (before study entry), (n = 70) Suppressed37 (52.9)37 (52.9)0 (0.0) Unsuppressed24 (34.3)24 (34.3)0 (0.0) Unknown9 (12.8)9 (12.8)0 (0.0) Number of sexual partners in the past 6 Months None6 (1.4)1 (1.2)5 (1.4) 1172 (39.0)35 (43.2)137 (38.1) ≥ 2263 (59.6)45 (55.6)218 (60.5)Median (IQR)2 (1–3)2 (1–2)2 (1–3) Condom use in the last 6 Months Always5 (1.1)1 (1.2)4 (1.1) Sometimes219 (49.7)40 (49.4)179 (49.7) Never217 (49.2)40 (49.4)177 (49.2) Number of UDS episodes in the past 6 Months None6 (1.4)1 (1.2)5 (1.4) 1291 (66.0)47 (58.0)244 (67.8) ≥ 2144 (32.6)33 (40.7)111 (30.8) Median (IQR)1 (1–2)1 (1–2)1 (1–2) Transactional sex in the past 6 months Yes200 (45.4)36 (44.4)164 (45.6) No241 (54.6)45 (55.6)196 (54.4) Alcohol intake in the last 6 Months Yes202 (45.8)51 (63.0)151 (41.9) No239 (54.2)30 (37.0)209 (58.1) Alcohol assessment (Audit-C scores) 0 (or no alcohol use)240 (54.4)30 (37.0)210 (58.3) 1–3115 (26.1)26 (32.1)89 (24.7) ≥ 486 (19.5)25 (30.9)61 (16.9)Illicit drug use in the past 6 Months (n = 439) d Yes39 (8.9)5 (6.2)34 (9.5) No400 (91.1)76 (93.8)324 (90.5) Partner notified of STI symptoms prior to clinic visit Yes206 (46.7)40 (49.4)166 (46.1) No235 (53.3)41 (50.6)194 (53.9)Sexual activity with UDS symptoms (n = 439)d Yes, with a condom20 (4.5)6 (7.6)14 (3.9) Yes, without a condom78 (17.8)22 (27.8)56 (15.6) No341 (77.7)51 (64.6)290 (80.5) Duration of UDS symptoms (days) 18 (1.8)1 (1.2)7 (1.9) 2–5183 (41.5)21 (25.9)162 (45.0) 6–996 (21.8)16 (19.8)80 (22.2) 10–1464 (14.5)17 (21.0)47 (13.1) > 1490 (20.4)26 (32.1)64 (17.8)UDS, Urethral Discharge Syndrome, M, month(s)d missing values; Sexually active since developed symptoms (n = 2, 0.5%), Drug use in past 6 months (n = 439, 0.5%). Participants who declined to answer the 2 questions were considered as missingThe Audit-C Score tool was used to identify participants who are hazardous drinkers or have active alcohol use disorders, with a score of 4 or higher indicative of hazardous alcohol intake Sociodemographic and behavior data characteristics stratified by HIV status for participants with UDS attending public health facilities in Kampala, Uganda UDS, Urethral Discharge Syndrome, M, month(s) d missing values; Sexually active since developed symptoms (n = 2, 0.5%), Drug use in past 6 months (n = 439, 0.5%). Participants who declined to answer the 2 questions were considered as missing The Audit-C Score tool was used to identify participants who are hazardous drinkers or have active alcohol use disorders, with a score of 4 or higher indicative of hazardous alcohol intake Overall, (8.6%) 7/81 were newly diagnosed during the study; median age was 28 years (IQR 20–39); 3/7 were aged < 25 years. Most reported sexual behaviors associated with HIV: 71.4% (5/7) reported ≥ 2 sexual partners in the past six months, 57.1% (4/7) reported never using condoms, and 57.1% (4/7) engaged in transactional sex. Additionally, 57.1% (4/7) reported hazardous alcohol use (AUDIT-C Score ≥ 4), and 57.1% (n = 4) had experienced ≥ 2 episodes of UDS within the previous six months (Supplemental Table 1). PLWH compared with those not living with HIV were more likely to engage in hazardous drinking, condomless sex with UDS symptoms, and have a longer duration of UDS symptoms (> 14 days). In the multivariable analysis, after adjustment for possible confounders, age ≥ 25 years (aPR, 6.35; 95% CI: 3.44–11.75, p < 0.001), and hazardous alcohol use (aPR,1.62; 95% C.I., 1.03–2.54; P = 0.038) were significantly associated with HIV (Table 2). Table 2Unadjusted and adjusted log binomial regression model for factors associated with a positive HIV test among men with UDS attending public health facilities in Kampala, UgandaVariableTotalN = 437PLWHTotaln = 79(18.1%)n (row%)UnadjustedAdjustedPR (95%CI)P-ValueaPR (95%CI)P-Value Age groups < 25 years23111 (4.8)RefRef≥25 years20667 (33.1)6.93 (3.77–12.74) < 0.001 6.35(3.44–11.75) < 0.001 Number of sex partners in the past 6 months None61 (16.7)Ref---1 partner17134 (19.9)1.19(0.19–7.32)0.849--≥ 2 partners26044 (16.9)1.02(0.17–6.20)0.987-- Condom use in the past 6 months Always51 (20.0)Ref---Sometimes21840 (18.4)0.92(0.16–5.41)0.924--Never21438 (17.8)0.89(0.15–5.25)0.896-- Number of UDS episodes in the past 6 months None61 (16.7)Ref---128846 (16.0)0.96 (0.16–5.84)0.963--≥ 214332 (22.4)1.34 (0.22–8.25)0.750-- Transactional sex in the past 6 months Yes19935 (17.6)0.95(0.64–1.42)0.808--No23844 (18.5)Ref-- Alcohol use in the past 6 months (Audit-C scores) No alcohol use (0 or no alcohol use)23729 (12.2)RefRef1–311526 (22.6)1.85(1.14–2.31) 0.012 1.43 (0.91–2.24)0.123≥ 48524 (28.2)2.31(1.42–3.73) 0.001 1.62 (1.03–2.54) 0.038 Drug use in the past 6 months Yes395 (12.8)0.69(0.30–1.60)0.388--No39873 (18.6)Ref-- Partner notification before clinic visit Yes20338 (18.7)Ref---No4141 (17.5)0.94(0.63–1.40)0.745-- Sexual activity with UDS symptoms Yes, with a condom206 (30.0)Ref---Yes, without a condom7822 (28.2)0.94(0.44-2.00)0.873--No33951 (15.0)0.50(0.25–1.03)0.059-- Duration of UDS symptoms (days) 181 (12.5)Ref-2–518221 (11.5)0.92(0.14–6.03)0.933--6–99516 (16.8)1.34(0.20–8.89)0.757--10–146316 (25.4)2.03(0.31–13.34)0.460--More than 148925 (28.1)2.24(0.35–14.48)0.394--PR denotes Prevalence ratios estimated using the Log binomial, CI confidence interval, and the reference category for a covariate in the model. Factors that had a P-value < = 0.2 at bivariable were included in the multivariable model fitted on 437 complete cases. A total of 4 cases were missing: unknown drug use in the past 6 months, n = 2 (2 HIV negative, 0 HIV positive), and declined to answer for sexually active since developed UDS symptoms, n = 2 (0 HIV negative, 2 HIV positive) Table 2Unadjusted and adjusted log binomial regression model for factors associated with a positive HIV test among men with UDS attending public health facilities in Kampala, UgandaVariableTotalN = 437PLWHTotaln = 79(18.1%)n (row%)UnadjustedAdjustedPR (95%CI)P-ValueaPR (95%CI)P-Value Age groups < 25 years23111 (4.8)RefRef≥25 years20667 (33.1)6.93 (3.77–12.74) < 0.001 6.35(3.44–11.75) < 0.001 Number of sex partners in the past 6 months None61 (16.7)Ref---1 partner17134 (19.9)1.19(0.19–7.32)0.849--≥ 2 partners26044 (16.9)1.02(0.17–6.20)0.987-- Condom use in the past 6 months Always51 (20.0)Ref---Sometimes21840 (18.4)0.92(0.16–5.41)0.924--Never21438 (17.8)0.89(0.15–5.25)0.896-- Number of UDS episodes in the past 6 months None61 (16.7)Ref---128846 (16.0)0.96 (0.16–5.84)0.963--≥ 214332 (22.4)1.34 (0.22–8.25)0.750-- Transactional sex in the past 6 months Yes19935 (17.6)0.95(0.64–1.42)0.808--No23844 (18.5)Ref-- Alcohol use in the past 6 months (Audit-C scores) No alcohol use (0 or no alcohol use)23729 (12.2)RefRef1–311526 (22.6)1.85(1.14–2.31) 0.012 1.43 (0.91–2.24)0.123≥ 48524 (28.2)2.31(1.42–3.73) 0.001 1.62 (1.03–2.54) 0.038 Drug use in the past 6 months Yes395 (12.8)0.69(0.30–1.60)0.388--No39873 (18.6)Ref-- Partner notification before clinic visit Yes20338 (18.7)Ref---No4141 (17.5)0.94(0.63–1.40)0.745-- Sexual activity with UDS symptoms Yes, with a condom206 (30.0)Ref---Yes, without a condom7822 (28.2)0.94(0.44-2.00)0.873--No33951 (15.0)0.50(0.25–1.03)0.059-- Duration of UDS symptoms (days) 181 (12.5)Ref-2–518221 (11.5)0.92(0.14–6.03)0.933--6–99516 (16.8)1.34(0.20–8.89)0.757--10–146316 (25.4)2.03(0.31–13.34)0.460--More than 148925 (28.1)2.24(0.35–14.48)0.394--PR denotes Prevalence ratios estimated using the Log binomial, CI confidence interval, and the reference category for a covariate in the model. Factors that had a P-value < = 0.2 at bivariable were included in the multivariable model fitted on 437 complete cases. A total of 4 cases were missing: unknown drug use in the past 6 months, n = 2 (2 HIV negative, 0 HIV positive), and declined to answer for sexually active since developed UDS symptoms, n = 2 (0 HIV negative, 2 HIV positive) Unadjusted and adjusted log binomial regression model for factors associated with a positive HIV test among men with UDS attending public health facilities in Kampala, Uganda Alcohol use in the past 6 months (Audit-C scores) PR denotes Prevalence ratios estimated using the Log binomial, CI confidence interval, and the reference category for a covariate in the model. Factors that had a P-value < = 0.2 at bivariable were included in the multivariable model fitted on 437 complete cases. A total of 4 cases were missing: unknown drug use in the past 6 months, n = 2 (2 HIV negative, 0 HIV positive), and declined to answer for sexually active since developed UDS symptoms, n = 2 (0 HIV negative, 2 HIV positive) Discussion In men with UDS attending public health facilities in Kampala District, Uganda, almost one-fifth were living with HIV; more than five times higher than the national HIV prevalence of 3.6% in 2023 among men aged ≥ 15 years [12]. This aligns with data from previous SSA studies demonstrating HIV prevalence among men with UDS is typically much higher than national averages [12, 22–25]. This analysis found that PLWH did not differ substantially from those without HIV across most sociodemographic and behavioural characteristics. Notably, men at risk reported sexual behaviours associated with HIV acquisition, including inconsistent condom use and multiple sexual partners. Our findings highlight that, regardless of HIV status, men with UDS broadly represent a population with enhanced vulnerabilities for poor sexual health outcomes and should be prioritized for integrated HIV testing to identify those with undiagnosed HIV and prevention interventions in those at risk for acquisition. STI service delivery points may therefore represent critical and underutilized opportunities to engage men in comprehensive sexual health services. Predictably, a positive HIV test was associated with older age, consistent with prior research [26]. Targeted HIV prevention interventions among younger men before sexual risk behaviours develop and become entrenched are needed, while ensuring timely diagnosis and treatment in older men. Hazardous alcohol use was also associated with prevalent HIV, consistent with prior studies in Africa that have described UDS in the context of overlapping HIV risk factors such as inconsistent condom use and recurrent STIs [27]. Similarities in behaviors between men with and without HIV suggest that focusing on traditional risk stratification may miss opportunities for prevention. Many participants in our study reported prior episodes of UDS, delays in seeking care, and low rates of partner disclosure, suggesting gaps in STI knowledge, stigma, or structural barriers to accessing timely care, which increase the risk of onward transmission. These findings underscore the need for strengthened STI education, improved risk awareness, earlier care-seeking, and partner engagement. Although data on the burden of HIV in Uganda among men with UDS are limited, findings from two Ugandan studies in comparable populations reported HIV prevalence of 20% with laboratory confirmation in 2001 [28], and 7.2% by self-report in 2019 [29]. Studies are required to investigate the efficacy of dual strategies to reduce the risk of HIV in Ugandan men with UDS and to improve VL suppression in those on ART, consistent with prior research [30]. Despite the national guidelines recommending routine HIV testing for all people with STI symptoms [16]. Our findings suggest inconsistent implementation across public health facilities within Kampala. More than one in twelve of those who were living with HIV were unaware of their positive status following their SOC visit and before study enrolment, indicating missed opportunities for HIV diagnosis within routine care for STI syndromes, consistent with previous research [31, 32]. Further research is required to strengthen provider adherence to national HIV testing guidelines for all patients with UDS, and to reduce individual-level barriers to HIV testing in STI care settings. New HIV diagnoses were fourfold higher among people who had never previously tested compared to those who reported a prior test. Almost all with prevalent HIV reported ART use; only half achieved recent viral suppression, below the 95% UNAIDS goal [33] and the national average of 75% among Ugandan men aged 15–49 years in 2023 [12]. While Undetectable=Untransmissible (U = U), defined as the absence of sexual HIV transmission among individuals with sustained viral suppression, is a well-established HIV prevention strategy endorsed globally and incorporated into national HIV responses, including in Uganda [34], its applicability in this population is limited by the low level of viral suppression; a substantial proportion of men may still have transmissible levels of HIV [30]. This study’s strengths include evaluating a population at high risk for HIV within real-world public health settings, using both behavioral and clinical data. However, the study has several limitations. First, the cross-sectional design precludes causal inference, and the identified demographic and sociobehavioral factors should therefore be interpreted as correlates of HIV positivity rather than causal determinants. Longitudinal studies are needed to establish temporality. Second, viral load suppression was based on self-report rather than laboratory confirmation, which may have introduced misclassification bias through inaccurate recall or misunderstanding of viral load status. Future studies should incorporate objective, laboratory-confirmed viral load measurements where feasible to reduce misclassification. Third, the purposive selection of public health facilities within urban Kampala may limit the generalizability of these findings, as men in private clinics, peri-urban, and rural settings may have different demographic profiles, health-seeking behaviours, and HIV risk, warranting validation of these findings across a broader range of contexts. Fourth, behavioural data collected via interviewer-administered questionnaires may have introduced social desirability bias, possibly resulting in underreporting of behaviours such as multiple partnerships and inconsistent condom use. Future studies should consider self-administered methods to encourage more candid reporting. Conclusions Men with UDS in Kampala are at high risk for HIV. These findings underscore the need for integrated HIV and STI services that strengthen routine HIV testing, prevention, and treatment support within STI care settings. Sexual health education, promoting earlier care-seeking, and improving partner notification are critical to reducing ongoing transmission. This accessible population could be prioritized for future longitudinal research to test both bacterial STI and HIV prevention strategies, enhanced HIV diagnosis, and to identify effective approaches for improving engagement across the HIV care continuum. Supplementary Information Below is the link to the electronic supplementary material. Supplementary Material 1 Supplementary Material 1